Business Context and Reporting Period
Company: Cocrystal Pharma, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 21, 2021
Reporting Period: Single event date (January 21, 2021)
Business Context: The filing discloses a scheduled presentation by Dr. Sam Lee, President of the Company, at the virtual 3rd Annual reimagine Health Research Symposium hosted by the University of Arizona College of Medicine.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a corporate event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document serves solely to disclose the upcoming presentation and the availability of the presentation materials.
Guidance, Outlook, and Risks
- Management Commentary: The Company is furnishing a presentation (Exhibit 99.1) to be used at the symposium.
- Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. It shall not be incorporated by reference into any Securities Act or Exchange Act filings.
- Availability: The presentation is available on the Company's website at www.cocrystalpharma.com.
Investor Verification Checklist
- Verify the content of the presentation (Exhibit 99.1) on the Company's website to understand the specific scientific or business updates being shared.
- Confirm that the presentation materials are not incorporated by reference into other regulatory filings, as explicitly stated in the disclaimer.
- Review the Company's subsequent filings (e.g., 10-K or 10-Q) for actual financial data, as this 8-K contains no financial figures.